61
Participants
Start Date
February 2, 2022
Primary Completion Date
October 1, 2027
Study Completion Date
October 1, 2027
PF-06835375
CXCR5 inhibitor
RECRUITING
Semmelweis University, Budapest
RECRUITING
Slade Pharmacy, Mount Kuring-Gai
RECRUITING
Liverpool Hospital, Liverpool
RECRUITING
South West Radiology, Liverpool
RECRUITING
Clinical Research Unit Haematology, Division of Cancer Services, St. George Hospital, Kogarah
RECRUITING
Calvary Mater Newcastle, Waratah
RECRUITING
The Alfred Hospital, Melbourne
RECRUITING
ICON Cancer Centre - Kurralta Park, Kurralta Park
RECRUITING
Flinders Medical Centre, Bedford Park
RECRUITING
Royal Perth Hospital, Perth
RECRUITING
Somogy Megyei Kaposi Mór Oktató Kórház, Kaposvár
RECRUITING
Pécsi Tudományegyetem Klinikai Központ, Pécs
RECRUITING
Petz Aladár Egyetemi Oktató Kórház, Győr
RECRUITING
Vseobecna fakultni nemocnice v Praze, Prague
RECRUITING
East Carolina University, Greenville
RECRUITING
Unity Health Toronto, St. Michael's Hospital, Toronto
RECRUITING
McGill University Health Centre, Montreal
RECRUITING
Fakultni nemocnice Hradec Kralove, Hradec Králové
RECRUITING
AIDPORT Sp. z o.o., Skórzewo
RECRUITING
InterHem, Bialystok
ACTIVE_NOT_RECRUITING
Klinika Hematologii i Transplantologii Uniwersyteckie Centrum Kliniczne, Gdansk
RECRUITING
Pratia Onkologia Katowice, Katowice
RECRUITING
Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan
RECRUITING
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw
NOT_YET_RECRUITING
Addenbrooke's Hospital, Cambridge
RECRUITING
Derriford Hospital, Plymouth
NOT_YET_RECRUITING
The Royal Cornwall Hospital, Truro
NOT_YET_RECRUITING
Hammersmith Hospital, London
Lead Sponsor
Pfizer
INDUSTRY